Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wakelkamp

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|December 9, 1997
Computational results may depend on personal computer processorM Wakelkamp
British Journal of Clinical Pharmacology|May 1, 1997
Natriuretic efficiency of frusemide as a consequence of drug input rateM Wakelkamp, G Alván, G Paintaud
British Journal of Clinical Pharmacology|March 7, 1998
The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemideM Wakelkamp, G Alván, G Paintaud
Clinical Pharmacokinetics|June 29, 1999
The efficiency concept in pharmacodynamicsG Alván, G Paintaud, M Wakelkamp
British Journal of Clinical Pharmacology|December 2, 1998
The influence of drug input rate on the development of tolerance to frusemideM Wakelkamp, G Alván, H Scheinin, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administrationM Wakelkamp, G Alván, J Gabrielsson, et al.
Pharmacogenetics|October 1, 1996
Formation of meprobamate from carisoprodol is catalysed by CYP2C19P Dalén, G Alvan, M Wakelkamp, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Dose proportional absorption of 25-150 mg atenololM Wakelkamp, G Alván, G Paintaud, et al.
British Journal of Clinical Pharmacology|October 6, 1999
The influence of frusemide formulation on diuretic effect and efficiencyM Wakelkamp, A Blechert, M Eriksson, et al.
Biopharmaceutics & Drug Disposition|April 1, 1995
The influence of food intake on the effect of two controlled release formulations of furosemideG Paintaud, G Alván, S A Eckernäs, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|December 9, 1997
Computational results may depend on personal computer processorM Wakelkamp
British Journal of Clinical Pharmacology|May 1, 1997
Natriuretic efficiency of frusemide as a consequence of drug input rateM Wakelkamp, G Alván, G Paintaud
British Journal of Clinical Pharmacology|March 7, 1998
The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemideM Wakelkamp, G Alván, G Paintaud
Clinical Pharmacokinetics|June 29, 1999
The efficiency concept in pharmacodynamicsG Alván, G Paintaud, M Wakelkamp
British Journal of Clinical Pharmacology|December 2, 1998
The influence of drug input rate on the development of tolerance to frusemideM Wakelkamp, G Alván, H Scheinin, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administrationM Wakelkamp, G Alván, J Gabrielsson, et al.
Pharmacogenetics|October 1, 1996
Formation of meprobamate from carisoprodol is catalysed by CYP2C19P Dalén, G Alvan, M Wakelkamp, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Dose proportional absorption of 25-150 mg atenololM Wakelkamp, G Alván, G Paintaud, et al.
British Journal of Clinical Pharmacology|October 6, 1999
The influence of frusemide formulation on diuretic effect and efficiencyM Wakelkamp, A Blechert, M Eriksson, et al.
Biopharmaceutics & Drug Disposition|April 1, 1995
The influence of food intake on the effect of two controlled release formulations of furosemideG Paintaud, G Alván, S A Eckernäs, et al.
Pageof 2